MedPath

Selection Criteria for Safe Hepatectomy for Hepatocellular Carcinoma

Completed
Conditions
Hepatectomy
Hepatecellular Carcinoma
Cirrhosis
Interventions
Procedure: Hepatectomy
Registration Number
NCT02056041
Lead Sponsor
University of Milan
Brief Summary

Selection criteria for safe hepatectomy for HCC are not well established. The aim of this study was the validation of the selection criteria for safe hepatectomy for hepatocellular carcinoma.

Detailed Description

All consecutive patients submitted to hepatectomy for HCC based on the same preoperative selection criteria from our prospectively-maintained liver unit database. Such criteria included the value of bilirubin (BIL), the value of cholinesterases (CHE), the presence of ascites, the presence of esophageal varices, and the rate of residual liver volume.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
336
Inclusion Criteria
  • any patient with HCC submitted to hepatic resection at our Unit in the established frame time
Exclusion Criteria
  • any patient with missing data or lost at follow-up

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Hepatectomy for HCCHepatectomyPatients submitted to surgery for HCC
Primary Outcome Measures
NameTimeMethod
Safety of surgery for HCC90 days

The primary endpoint was the validation of our selection criteria for safe hepatectomy for HCC in regards to postoperative complications. The role of total bilirubin and cholinesterases was analzyed together with other clinical parameters.

Secondary Outcome Measures
NameTimeMethod
Score systems HCC90 days

The secondary endpoint was the testing of the most common score systems for HCC, which are the CPT score, the MELD score, and the APRI score.

Trial Locations

Locations (1)

Humanitas Research Hospital

🇮🇹

Rozzano, Milan, Italy

© Copyright 2025. All Rights Reserved by MedPath